Re:Experts Have Resigned from an FDA Committee over Alzheime...
by Brakenshire on Wednesday September 22, 2021 @05:30PM
(#28622109)
I agree, that's well put and I think that could work very well.
I think the key would be having clear centralized standards for how the trials are conducted, or you could have doctors skirting the system and just using it as de-facto prescription, and patients being put at risk for ineffective treatment without producing any valid evidence.
Re:Experts Have Resigned from an FDA Committee over Alzheime...
by civilized on Wednesday September 22, 2021 @06:06PM
(#28622593)
Yeah, if the existing system is built on trust of doctors who run clinical trials, we have to ask whether that trust scales.
If the system were set up so that doctors would have a lot to lose if they didn't follow the system, trust could work here. We already trust doctors as professionals on many other things...
Re:Experts Have Resigned from an FDA Committee over Alzheime...
by ezconnect on Wednesday September 22, 2021 @09:10PM
(#28624117)
His proposal is to treat a new disease with approved drug you can buy and not experimental drugs. This will give us more data on therapies that might work and we can do more detailed studies on therapies with high percentage of recoveries.
Now, imagine that after safety is verified to a 1 or 2-star level, we don't make the drug approved for general use, but doctors can freely enroll in randomized trials as you proposed? That way we're getting the efficacy data quickly but safely.
Maybe a minor point, but we do have to unbundle safety from efficacy in some sense to get off the ground here. The question is, what exactly is allowed to happen after safety is established but efficacy is not yet established?